Na Xu

机构：Tongji Hospital, Huazhong University of Science and Technology

发表论文 217 篇 · 总被引 2341 次 · h-index 25

代表论文

• Efficacy and safety of third-generation CD19-CAR T cells incorporating CD28 and TLR2 intracellular domains for B-cell malignancies with central nervous system involvement: results of a pivotal trial (2025 · Journal of Translational Medicine · 被引 14)
• Haploidentical peripheral blood stem cells combined with bone marrow or unrelated cord blood as grafts for haematological malignancies: an open-label, multicentre, randomised, phase 3 trial (2025 · The Lancet Haematology · 被引 9)
• Metagenomic Next-Generation Sequencing in the Diagnosis of Pulmonary Infections after Allogeneic Hematopoietic Stem Cell Transplantation (2024 · Transplantation and Cellular Therapy · 被引 9)
• Olverembatinib (HQP1351)-based therapy in adults with relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia or chronic myeloid leukemia in blast phase: results from a real-world study (2025 · Frontiers in Immunology · 被引 5)
• Decitabine combined with reduced-intensity conditioning for older patients with acute myeloid leukemia in composite complete remission undergoing allogeneic hematopoietic stem cell transplantation: a multicenter, single-arm, phase 2 trial (2025 · The Lancet Regional Health - Western Pacific · 被引 3)
• GPX1 confers resistance to metabolic stress in BCR/ABL-T315I mutant chronic myeloid leukemia cells (2025 · Cell Death Discovery · 被引 3)